Hutch News

Stories tagged 'chemotherapy'

Palliative care: It’s not what you think (or fear)

Stigma keeps many cancer patients from using a service that offers much-needed help to the sick as well as the dying

April 26, 2017 | By Diane Mapes / Fred Hutch News Service

Palliative care isn't just about easing suffering at end of life. It’s also appropriate for patients dealing with pain or side effects anywhere along the cancer continuum. But not all patients, or doctors, realize this. Two Fred Hutch experts discuss the latest research, and the stigma, surrounding this crucial type of care.

View story >


Love in the time of cancer

Getting dumped after diagnosis isn’t the only story out there; meet three couples who found romance despite disease

Feb. 14, 2017 | By Diane Mapes / Fred Hutch News Service

Getting dumped after diagnosis isn’t the only plotline when it comes to love and cancer. Fred Hutch News Service talked to three couples who found romance despite disease. This Valentine's Day, we share their stories.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 2, 2017

Novel gene therapy for sickle cell disease and related disorders on the horizon; immunotherapy trial in rare skin cancer named one of 2016’s major advances in clinical cancer research and care; Dr. Cara McDermott receives AcademyHealth new investigator award; and study documents sperm changes years after chemotherapy.

View story >


Clearing up another mammogram muddle

Confused about the latest breast-cancer screening study? Fred Hutch, SCCA experts have answers

Jan. 11, 2017 | By Diane Mapes / Fred Hutch News Service

We tapped experts at Fred Hutch and Seattle Cancer Care Alliance for their thoughts on a new study and commentary that have raised questions about the value of mammography and how it can sometimes lead to overtreatment.

View story >


Common genetic disorder linked to increased death rate from cancer drug

Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome

Oct. 27, 2016 | By Susan Keown / Fred Hutch News Service

As many as one of every 10 people has Gilbert's syndrome, which is typically benign and has even been linked to long life. But new research suggests that busulfan, a bone marrow transplant drug, is extra risky in people with the condition.

View story >


Alternative reality: Patients who spurn chemo for natural remedies

What oncologists do – and say – when their patients choose holistic treatments over conventional care

May 27, 2016 | By Bill Briggs / Fred Hutch News Service

What oncologists do – and say – when their patients choose holistic treatments over conventional cures.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.